GlassScriptPhysician profile
Robert D Sawyer
NPI 1629241146
$249,446.25
in general payments reported to CMS, 2019-2025
52 companies · $19K in 2025
The $19K reported for 2025 was more than what 92% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,409 · 2020: $23K · 2021: $53K · 2022: $64K · 2023: $60K · 2024: $23K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $94K · Food and Beverage: $5,601 · Travel and Lodging: $2,684 · Education: $27.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $93,656.25 |
| Food and Beverage | $5,600.83 |
| Travel and Lodging | $2,684.44 |
| Education | $27.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $134,637.85 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $95,180.24 | 2020-2025 | Jardiance, Zepbound |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $6,058.09 | 2019-2025 | Lifevest |
| Abbott Laboratories | $3,291.24 | 2019-2025 | Dragonfly Opstar, Optis, Cardiomems |
| Astrazeneca Pharmaceuticals LP | $1,801.56 | 2019-2024 | Wainua, Lokelma, Brilinta |
| Janssen Pharmaceuticals, INC | $1,601.62 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $1,561.64 | 2019-2024 | Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Amgen INC. | $592.33 | 2019-2025 | Repatha, Repatha |
| Abiomed | $427.39 | 2023-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $389.86 | 2022-2025 | Eliquis, Camzyos |
| Inari Medical, INC. | $383.44 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $361.86 | 2019-2025 | |
| Medtronic, INC. | $337.33 | 2022-2024 | Onyx Frontier, Corevalve Evolut R |
| Novo Nordisk INC | $335.38 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $196.44 | 2019-2024 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $184.05 | 2021-2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $182.18 | 2019-2024 | |
| Philips North America LLC | $180.28 | 2022-2025 | (5091) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided, (Cm9) Amb Mon & Diag Und |
| Merck Sharp & Dohme LLC | $148.50 | 2022-2025 | Verquvo |
| Shockwave Medical, INC | $125.98 | 2021 | |
| Alnylam Pharmaceuticals INC. | $123.49 | 2023-2025 | Onpattro |
| Asahi Intecc USA, INC. | $121.90 | 2019 | |
| Irhythm Technologies, INC. | $118.51 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Edwards Lifesciences Corporation | $115.85 | 2025 | Sapien 3 Ultra Resilia |
| Actelion Pharmaceuticals US, INC. | $104.98 | 2020-2023 | Uptravi |
| Azurity Pharmaceuticals, INC. | $81.54 | 2023-2024 | Edarbi, Edarbi |
| Regeneron Healthcare Solutions, INC. | $79.79 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $69.58 | 2022-2024 | |
| Heartflow, INC. | $66.73 | 2025 | |
| Amarin Pharma, INC. | $61.53 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $44.26 | 2024 | |
| Akcea Therapeutics, INC. | $43.47 | 2020-2021 | |
| Stryker Corporation | $35.76 | 2025 | Flowtriever |
| Impulse Dynamics (USA) INC. | $33.72 | 2022 | |
| Siemens Medical Solutions USA, INC. | $28.95 | 2019 | |
| Atricure, INC. | $28.36 | 2023 | |
| Arbor Pharmaceuticals, INC. | $28.13 | 2021-2022 | |
| Lundbeck LLC | $25.29 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $24.71 | 2024 | Arcalyst |
| Thrombolex, INC. | $24.58 | 2024 | Bashir Endovascular Catheter |
| Ge Healthcare | $23.84 | 2023 | |
| Glaxosmithkline, LLC. | $23.71 | 2025 | Arexvy, Shingrix |
| Inspire Medical Systems, INC. | $22.99 | 2025 | Inspire |
| Baxter Healthcare | $22.45 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Zoll Respicardia, INC. | $21.53 | 2022 | |
| Terumo Medical Corporation | $19.91 | 2025 | Metacross Otw, Tr Band, Angio-Seal |
| Angiodynamics, INC. | $16.82 | 2025 | Alphavac |
| Kiniksa Pharmaceuticals, LTD. | $16.08 | 2022 | |
| Cardiva Medical, INC. | $13.93 | 2023 | Cardiva Vascade 6/7f Vcs |
| Medtronic Vascular, INC. | $13.38 | 2019 | |
| Chiesi USA, INC. | $13.22 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sawyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.